Skip to content

Clinical trials

Phase 2/3 trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Singapore Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20061
20072
20081
20092
20102
20112
20125
20133
20142
20156
20165
20176
20185
20192
20206
20213
20224
20234
20243
20259
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Recruiting13
Terminated11
Unknown status11
Active, not recruiting10
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National University Hospital, Singapore8
National University of Singapore4
Novartis Pharmaceuticals4
AbbVie3
Bayer3
Bristol-Myers Squibb3
Changi General Hospital3
Hoffmann-La Roche3
KK Women's and Children's Hospital3
Singapore General Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung5
Stomach Neoplasms5
Disease3
Lung Neoplasms3
Neoplasms3
Breast Neoplasms2
COVID-192
Carcinoma, Ovarian Epithelial2
Cognitive Dysfunction2
Colitis, Ulcerative2

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.